MedTrace Logo

Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas

NCT07218224 · Status: AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2025-10-17

No results posted yet for this study

Summary

This expanded access protocol is proposed to allow University of California San Francisco (UCSF) patients additional access to 18F-fluorocholine (FCH) Positron Emission Tomography (PET) imaging for localization of parathyroid adenomas.

Conditions

  • Parathyroid Adenomas

Interventions

DRUG

18F-Fluorocholine (FCH)

A dose of 4-7 millicurie (mCi) +/- 10% of radiotracer 18F-Fluorocholine (FCH) manufactured at UCSF will be given intravenously.

PROCEDURE

Positron emission tomography (PET)

A scan is a procedure that produces images of organs and tissues used in conjunction with a radiotracer.

Sponsors & Collaborators

  • Thomas Hope

    lead OTHER

Principal Investigators

  • Thomas Hope, MD · University of California, San Francisco

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07218224 on ClinicalTrials.gov